$31.00
Manufacturer: Ukraine
Laferon-of PharmBiotek is used in the treatment of: acute and chronic viral hepatitis B (moderate and severe forms); chronic hepatitis C; acute viral, bacterial and mixed infections (including acute respiratory viral infection in children, including newborns, acute diarrhoeal syndrome in newborns, acute intestinal infections in young children with hypocoagulation phenomena); acute and chronic septic diseases of viral and bacterial nature, including disseminated forms of acute and chronic sepsis; herpetic infections of various localization: shingles, multiple skin herpetic rashes; genital herpetic infection;
Description
Laferon-Farmbiotek Composition
active substance: recombinant human interferon alpha-2b;
1 suppository contains recombinant human interferon alpha-2b 250 thousand IU, 500 thousand IU, 1 million IU or 3 million IU;
excipients: dextran 70, polysorbate 80, citric acid monohydrate, sodium hydroxide, disodium edetate, emulsifier T-2, solid fat.
Laferon-Farmbiotek Dosage form
Rectal suppositories.
Basic physical and chemical properties: suppository of a cylindrical shape with a pointed end, from white to light yellow color of a uniform consistency, the presence of a funnel-shaped depression on the cut is allowed.
Laferon-Farmbiotek Pharmacological group
Immunostimulants. Interferon alpha-2b. ATX code L03A B05.
Pharmacological properties
Pharmacodynamics
Laferon-PharmBiotek® has a wide spectrum of biological activity. Of paramount importance is the pronounced antiviral and immunostimulating effect, as well as the activation of antitumor protection. Interferons (IFN) regulate the relationship between the links of cellular and humoral immunity. Under the influence of IFN, the differentiation and activity of natural killer cells and T-lymphocytes increases, which determines the active course of cellular immunity reactions. IFNs regulate the production of inflammatory mediators, affect the migration of inflammatory cells to the pathological focus, stimulate phagocytosis and other bactericidal reactions, normalizing the dynamics of the inflammatory process. IFNs also directly inhibit viral replication and transcription; affect the main stages of replication of intracellular pathogens, stopping their reproduction, provide effective lysis of infectious agents. IFNs are characterized by high antiviral and anti-Chlamydial activity.
The use of Laferon-PharmBiotek® as part of the complex treatment of chronic infectious and inflammatory diseases can increase the effectiveness of antibacterial and other drugs that are used for treatment, as well as reduce their systemic toxic effect, and shorten the duration of treatment.
Laferon-Farmbiotek Pharmacokinetics
Has not been studied.
Indications
Laferon-PharmBiotek®, rectal suppositories, are used in children and adults as monotherapy and as part of complex treatment for various viral and viral-bacterial infections. The drug is indicated for use in:
– flu and ARVI,
– viral and bacterial infections of the respiratory tract,
– childhood viral infectious diseases (mumps, measles, rubella, chickenpox, mononucleosis),
– rotavirus infection,
– chronic viral hepatitis B in children,
– intrauterine infections (TORCH infections), pneumonia, sepsis, meningitis in children,
– dysplasia of the cervix associated with the human papillomavirus,
– chronic infectious and inflammatory diseases of the urogenital tract.
The drug is used to rehabilitate children who often suffer from respiratory infections.
Contraindications
Individual intolerance to interferon alpha-2b and other components that make up the drug, a history of severe allergic diseases. The period of pregnancy or lactation.
Recent Reviews